Can you explain to me why you would have MSB ramp up production when there is no guarantee a product will be approved by FDA?
Why should MSB take the risk? If more die, it is on FDA's head for not approving use in aGVHD (despite 9 to 1 experts wanting it approved).
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-430
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.028(2.59%) |
Mkt cap ! $1.218B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $1.834M | 1.701M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 20309 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 36377 | 5 |
View Market Depth
| Last trade - 13.09pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |